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Long Stents are Likely to be Under-expanded with Stent Delivery Balloon, Post-
stent Optimal Coherence Tomography Assessment
Hiroyuki Shibata1, Yoichi Kijima1, Tomoya Masano1, Ryoji Nagoshi1,
Amane Kozuki1, Kimitake Imamura1, Yoshiro Tsukiyama1, Kenichi Yanaka1,
Shinsuke Nakano1, Junya Shite1
1Osaka Saiseikai Nakatsu Hospital, Osaka, Japan
Background: The 2nd generation DES improved the clinical outcome, however, stent
underexpansion and malapposition should be avoided to prevent stent restenosis and
subacute stent thrombosis (DES failure). Previous study showed that stent length was
strongly associated with DES failure.
Methods: We investigated 172 de novo coronary lesions without calciﬁcation treated
with single 2nd generation DES (Xience Prime, Promus Element, Nobori, and
Resolute Integrity) under optical coherence tomography (OCT) guidance. After
deployment of DES with stent delivery balloon by 2 or 3 times inﬂations, minimum
stent area (MSA) and distance between the strut and vessel wall of malapposed struts
were analyzed by OCT. We also calculated a ratio of measured MSA to estimated
stent area (M/E ratio) obtained by compliance chart in each DES. Long stent was
deﬁned that stent length was 28-38mm and short stent was less than 28mm. We
compared long stent group (N¼46) with short stent group (N¼126).
Results: Baseline and lesion characteristics were similar between two groups.
However, M/E ratio of MSA in long stent group was signiﬁcantly smaller than that in
short stent group (0.59 vs. 0.66 p¼0.001). The distance between the strut and vessel
wall of malapposed struts in long stent group was larger than that in short stent group
(0.319 vs. 0.245mm, p¼0.015).
Conclusions: Long stent did not achieve optimal stent expansion with delivery
balloon even in non-calciﬁed lesion. After stent deployment, we should perform
OCT to evaluate stent under expansion and stent malapposition, and assess
whether another post dilatation balloon is needed or not, especially in long
stenting.Long stent
(28mm)
N=46
Short stent
(<28mm)
N=126 p value
Age 66.4 68.5 0.289
Male, % 72.7 71.3 0.860
Diabetes Mellitus, % 56.5 43.6 0.136
Hypertension, % 78.3 73.8 0.553
Dyslipidemia, % 65.2 57.9 0.391
Stent size, mm 2.70 2.82 0.095
Stent Inﬂation
pressure, atm
10.7 11.5 0.038
Minimum stent
area, mm2
3.66 4.58 0.002
Maximum stent
area, mm2
6.16 6.66 0.174
Estimated stent
area,mm2
6.18 6.86 0.056
Ratio of measured
/ Estimated stent
area
0.59 0.66 0.001
Ratio of minimum
/ maximum stent
area
0.63 0.73 <0.0001
Distance of stent
malapposition, mm
0.319 0.245 0.015
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Comparative incidence of optical coherence tomography features indicative of
uncorrected stent deployment in patients with and without major adverse cardiac
events in the OCT guided arm of the CLI-OPCI study
Laura Gatto1, Alberto Chisari2, Alessio La Manna3, Francesco Burzotta4,
Luca Di Vito1, Maria Teresa Mallus5, Alberto Cremonesi6, Alessandro Pappalardo5,
Mario Albertucci5, Francesco Prati7
1San Giovanni Addolorata Hospital, Roma, Italy, 2University of Catania, Cardiology,
Italy, 3Ferrarotto Hospital, Catania, Catania, Italy, 4Catholic University Hospital of
the Sacred Heart, Roma, Italy, 5s. giovanni hospital, rome, Italy, 6N/A, Cotignola,
Italy, 7San Giovanni Hospital, Rome, Italy
Background: The Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous
Coronary Intervention study suggested that the use of optical coherence tomography
(OCT) can improve the clinical outcome in patients undergoing PCI. The aim of this
study was to compare the incidence of the OCT-features predicting adverse events in
patients who suffered from cardiac death or myocardial infarction (MACE group)
respect to patients who had no MACE (Control group).
Methods: 22 patients out of 335 had a MACE at 1 year of follow-up (MACE group)
vs the remaining 313 without complications (Control group). Stents were assessed by
OCT to address the features indicative of non-optimal stent deployment such as stent
under-expansion, malapposition, edge dissection, thrombus burden and reference
lumen narrowing. OCT images were analysed applying the quantitative thresholds of
the CLI-OPCI study.
Results: The OCT features indicative of non-optimal stent deployment were observed
more frequently in the MACE group compared to the Control group (ﬁgure 1).
Excluding malapposition, that did not differ in the 2 groups, the percentage of cases
which had at least one of the OCT missed criteria was signiﬁcantly higher in the
MACE group (89% vs 39%, P<0.001).P
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SConclusions: Patients with MACE in the CLI-OPCI study despite the use of OCT
guided strategy were found to have more often an uncorrected stent deployment based
on the OCT criteria. These results further emphasizes the role of OCT in optimizing
stent implantation.
TCT-556
Differences in neointimal coverage among bare-metal stent, zotarolimus-eluting
stent, everolimus-eluting stent and biolimus–eluting stent at 9 months after
implantation using optical coherence tomography in patients with ST-segment
elevation myocardial infarction
Koichiro Sonoda1, Shiro Hata1, Satoshi Ikeda2, Seiji Koga2, Koji Maemura2
1Sasebo City General Hospital, Sasebo, Japan, 2Nagasaki University Graduate
School of Biomedical Sciences, Nagasaki, Japan
Background: Percutaneous coronary intervention with drug-eluting stents for patients
with ST-segment elevation myocardial infarction (STEMI) reduces target lesion
revascularization, but drug-eluting stents have an increased risk of very late stent
thrombosis. Endothelial coverage of stents is a key factor in stent thrombosis. This
study examined neointimal coverage of bare-metal stent (BMS), and 3 types of
second-generation drug-eluting stents [zotarolimus-eluting stent (E-ZES), everolimus-
eluting stent (EES) and biolimus-eluting stent (BES)] in STEMI patients using optical
coherence tomography (OCT).
Methods: Eighty-eight STEMI patients underwent follow-up coronary angiography
and OCT at 9 months after stent implantation (BMS, n¼22; E-ZES, n¼21; EES,
n¼22; BES, n¼23). Using OCT, we measured thickness inside every strut and area
between struts and vessel wall, and evaluated neointimal coverage and malapposition
of stents. The relationship of strut condition to remodeling index before Percutaneous
coronary intervention by intravascular ultrasound was also examined.
Results: As shown in the table 1, restenosis rate, neointimal coverage thickness and
area rate were signiﬁcantly lower with EES and BES than with BMS and E-ZES,
while the malapposed rate was signiﬁcantly higher in EES and BES. Uncovered struts
were most frequently observed in EES. In addition, evagination/strut rate was highestacts/POSTER/Intravascular Imaging and PCI B167
